.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Chubb
Harvard Business School
Mallinckrodt
AstraZeneca
Argus Health
Cantor Fitzgerald
Chinese Patent Office
Colorcon
Boehringer Ingelheim

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012366

« Back to Dashboard
NDA 012366 describes SOMA COMPOUND W/ CODEINE, which is a drug marketed by Meda Pharms and is included in one NDA. Additional details are available on the SOMA COMPOUND W/ CODEINE profile page.

The generic ingredient in SOMA COMPOUND W/ CODEINE is aspirin; carisoprodol; codeine phosphate. There are twenty-one drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.

Summary for NDA: 012366

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength325MG;200MG;16MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
Approval Date:Jul 11, 1983TE:RLD:No

Expired Orange Book Patents for NDA: 012366

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Meda Pharms
SOMA COMPOUND W/ CODEINE
aspirin; carisoprodol; codeine phosphate
TABLET;ORAL012366-002Jul 11, 1983► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Baxter
Merck
Harvard Business School
Farmers Insurance
Johnson and Johnson
Teva
Moodys
US Army
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot